DURHAM, N.C.--(BUSINESS WIRE)--Inspire Pharmaceuticals, Inc. (NASDAQ:ISPH) announced today the approval of non-qualified stock option (“Options”) and restricted stock unit (“RSUs”) grants to Inspire’s Executive Vice President of Research and Development and Chief Medical Officer, Charles Johnson, M.D., pursuant to NASDAQ Marketplace Rule 5635(c)(4).
